Host defense (antimicrobial) peptide, human β-defensin-3, improves the function of the epithelial tight-junction barrier in human keratinocytes

Journal of Investigative Dermatology

Volumn 134, Issue 8, 2014, Pages 2163-2173

  Kiatsurayanon, Chanisa ^a   Niyonsaba, François ^a   Smithrithee, Rithee ^a   Akiyama, Toshihiro ^a   Ushio, Hiroko ^a   Hara, Mutsuko ^a   Okumura, Ko ^a   Ikeda, Shigaku ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CHEMOKINE RECEPTOR CCR6; CLAUDIN; CLAUDIN 1; CLAUDIN 11; CLAUDIN 14; CLAUDIN 17; CLAUDIN 20; CLAUDIN 23; CLAUDIN 25; CLAUDIN 5; CLAUDIN 9; GLYCOGEN SYNTHASE KINASE 3; OCHRATOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C DELTA; PROTEIN KINASE C LAMBDA; RAC1 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN CONDUCTANCE; TIGHT JUNCTION; TRANSEPITHELIAL ELECTRICAL RESISTANCE;

BETA-DEFENSINS; CELLS, CULTURED; ELECTRIC IMPEDANCE; EPITHELIUM; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNITY, INNATE; KERATINOCYTES; OCHRATOXINS; PERMEABILITY; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN KINASE C; RAC1 GTP-BINDING PROTEIN; RECEPTORS, CCR6; TIGHT JUNCTIONS;

EID: 84904501812     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.143     Document Type: Article

References (64)

1. Ali RS, Falconer A, Ikram M et al. (2001) Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 117:106-11
2. Anderson JM, Van Itallie CM (2009) Physiology and function of the tight junction. Cold Spring Harb Perspect Biol 1:a002584
3. Andras IE, Pu H, Tian J et al. (2005) Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J Cereb Blood Flow Metab 25:1159-70
4. Bachelder RE, Yoon SO, Franci C et al. (2005) Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: Implications for the epithelial-mesenchymal transition. J Cell Biol 168:29-33
5. Bakin AV, Tomlinson AK, Bhowmick NA et al. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 275:36803-10
6. Baroni A, Buommino E, De Gregorio V et al. (2012) Structure and function of the epidermis related to barrier properties. Clin Dermatol 30:257-62
7. Baumer Y, Spindler V, Werthmann RC et al. (2009) Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J Cell Physiol 220:716-26
8. Bhat RV, Shanley J, Correll MP et al. (2000) Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc Natl Acad Sci USA 97:11074-9
9. Brandner JM (2009) Tight junctions and tight junction proteins in mammalian epidermis. Eur J Pharm Biopharm 72:289-94
10. Brandner JM, Kief S, Grund C et al. (2002) Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 81:253-63
11. Calautti E, Li J, Saoncella S et al. (2005) Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death. J Biol Chem 280: 32856-65
12. Capaldo CT, Nusrat A (2009) Cytokine regulation of tight junctions. Biochim Biophys Acta 1788:864-71
13. Chen X, Macara IG (2005) Par-3 controls tight junction assembly through the Rac exchange factor Tiam1. Nat Cell Biol 7:262-9
14. De Benedetto A, Rafaels NM, McGirt LY et al. (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127:e1-7
15. Doble BW, Woodgett JR (2003) GSK-3: Tricks of the trade for a multi-tasking kinase. J Cell Sci 116:1175-86
16. Efimova T, Broome AM, Eckert RL (2004) Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex. Mol Cell Biol 24:8167-83
17. Ferry X, Brehin S, Kamel R et al. (2002) G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides 23:1507-15
18. Fulton C, Anderson GM, Zasloff M et al. (1997) Expression of natural peptide antibiotics in human skin. Lancet 350:1750-1
19. Furuse M, Furuse K, Sasaki H et al. (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol 153:263-72
20. Furuse M, Hata M, Furuse K et al. (2002) Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from claudin-1-deficient mice. J Cell Biol 156:1099-111
21. Ganz T (2003) Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-20
22. Garcia JR, Krause A, Schulz S et al. (2001) Human beta-defensin 4: A novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 15:1819-21
23. Gonzalez-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signaling pathways. Biochim Biophys Acta 1778: 729-56
24. Harder J, Bartels J, Christophers E et al. (1997) A peptide antibiotic from human skin. Nature 387:861
25. Harder J, Bartels J, Christophers E et al. (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-13
26. Harder J, Meyer-Hoffert U, Wehkamp K et al. (2004) Differential gene induction of human beta-defensins (hBD-1,-2,-3, and-4) in keratinocytes is inhibited by retinoic acid. J Invest Dermatol 123:522-9
27. Helfrich I, Schmitz A, Zigrino P et al. (2007) Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation. J Invest Dermatol 127:782-91
28. Itoh K, Kawasaki S, Kawamoto S et al. (2005) Identification of differentially expressed genes in psoriasis using expression profiling approaches. Exp Dermatol 14:667-74
29. Jamaluddin MS, Wang X, Wang H et al. (2009) Eotaxin increases monolayer permeability of human coronary artery endothelial cells. Arterioscler Thromb Vasc Biol 29:2146-52
30. Kirschner N, Poetzl C, von den Driesch P et al. (2009) Alteration of tight junction proteins is an early event in psoriasis: Putative involvement of proinflammatory cytokines. Am J Pathol 175:1095-106
31. Kirschner N, Rosenthal R, Furuse M et al. (2013) Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol 133:1161-9
32. Koivisto L, Alavian K, Hakkinen L et al. (2003) Glycogen synthase kinase-3 regulates formation of long lamellipodia in human keratinocytes. J Cell Sci 116:3749-60
33. Lambert D, Padfield PJ, McLaughlin J et al. (2007) Ochratoxin A displaces claudins from detergent resistant membrane microdomains. Biochem Biophys Res Commun 358:632-6
34. Little D, Dean RA, Young KM et al. (2003) PI3K signaling is required for prostaglandin-induced mucosal recovery in ischemia-injured porcine ileum. Am J Physiol Gastrointest Liver Physiol 284:G46-56
35. Liu AY, Destoumieux D, Wong AV et al. (2002) Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118:275-81
36. Matter K, Balda MS (2003) Functional analysis of tight junctions. Methods 30:228-34
37. McLaughlin J, Padfield PJ, Burt JP et al. (2004) Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms. Am J Physiol Cell Physiol 287:C1412-7
38. Mertens AE, Rygiel TP, Olivo C et al. (2005) The Rac activator Tiam1 controls tight junction biogenesis in keratinocytes through binding to and activation of the Par polarity complex. J Cell Biol 170:1029-37
39. Milatz S, Krug SM, Rosenthal R et al. (2010) Claudin-3 acts as a sealing component of the tight junction for ions of either charge and uncharged solutes. Biochim Biophys Acta 1798:2048-57
40. Nagaoka I, Niyonsaba F, Tsutsumi-Ishii Y et al. (2008) Evaluation of the effect of human beta-defensins on neutrophil apoptosis. Int Immunol 20:543-53
41. Niessen CM (2007) Tight junctions/adherens junctions: Basic structure and function. J Invest Dermatol 127:2525-32
42. Niyonsaba F, Nagaoka I, Ogawa H (2006) Human defensins and cathelicidins in the skin: Beyond direct antimicrobial properties. Crit Rev Immunol 26:545-76
43. Niyonsaba F, Nagaoka I, Ogawa H et al. (2009) Multifunctional antimicrobial proteins and peptides: Natural activators of immune systems. Curr Pharm Des 15:2393-413
44. Niyonsaba F, Ushio H, Nagaoka I et al. (2005) The human beta-defensins (-1,-2,-3,-4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes. J Immunol 175:1776-84
45. Niyonsaba F, Ushio H, Nakano N et al. (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127:594-604
46. Nomura I, Goleva E, Howell MD et al. (2003) Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171:3262-9
47. Nusrat A, Chen JA, Foley CS et al. (2000) The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem 275:29816-22
48. Ong PY, Ohtake T, Brandt C et al. (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-60
49. Peltonen S, Riehokainen J, Pummi K et al. (2007) Tight junction components occludin, ZO-1, and claudin-1,-4 and-5 in active and healing psoriasis. Br J Dermatol 156:466-72
50. Rohrl J, Yang D, Oppenheim JJ et al. (2010) Human beta-defensin 2 and 3 and their mouse orthologs induce chemotaxis through interaction with CCR2. J Immunol 184:6688-94
51. Sayas CL, Avila J, Wandosell F (2002) Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms. J Neurosci 22:6863-75
52. Severson EA, Kwon M, Hilgarth RS et al. (2010) Glycogen Synthase Kinase 3 (GSK-3) influences epithelial barrier function by regulating occludin, claudin-1 and E-cadherin expression. Biochem Biophys Res Commun 397:592-7
53. Sorensen OE, Cowland JB, Theilgaard-Monch K et al. (2003) Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 170:5583-9
54. Tscharntke M, Pofahl R, Chrostek-Grashoff A et al. (2007) Impaired epidermal wound healing in vivo upon inhibition or deletion of Rac1. J Cell Sci 120:1480-90
55. Turksen K, Troy TC (2002) Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 129:1775-84
56. Turner JR, Angle JM, Black ED et al. (1999) PKC-dependent regulation of transepithelial resistance: Roles of MLC and MLC kinase. Am J Physiol 277:C554-62
57. Van Itallie CM, Anderson JM (2006) Claudins and epithelial paracellular transport. Annu Rev Physiol 68:403-29
58. Wang WC, Tsai JJ, Kuo CY et al. (2011) Non-proteolytic house dust mite allergen, Der p 2, upregulated expression of tight junction molecule claudin-2 associated with Akt/GSK-3beta/beta-catenin signaling pathway. J Cell Biochem 112:1544-51
59. Watson RE, Poddar R, Walker JM et al. (2007) Altered claudin expression is a feature of chronic plaque psoriasis. J Pathol 212:450-8
60. Wilsmann-Theis D, Hagemann T, Jordan J et al. (2008) Facing psoriasis and atopic dermatitis: Are there more similarities or more differences? Eur J Dermatol 18:172-80
61. Wolburg H, Wolburg-Buchholz K, Kraus J et al. (2003) Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105:586-92
62. Wu Z, Hoover DM, Yang D et al. (2003) Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc Natl Acad Sci USA 100:8880-5
63. Yuki T, Hachiya A, Kusaka A et al. (2011) Characterization of tight junctions and their disruption by UVB in human epidermis and cultured keratinocytes. J Invest Dermatol 131:744-52
64. Yuki T, Haratake A, Koishikawa H et al. (2007) Tight junction proteins in keratinocytes: Localization and contribution to barrier function. Exp Dermatol 16:324-30